CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 382 target
Drug / intervention
Serial Electrocardiogramsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01953276
NCT01953276N/ACompleted

Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain (ASAP CATH) Study

Wake Forest University Health Sciences·observational·Posted Sep 30, 2013·Updated Feb 17, 2022

In Brief

An observational study evaluating Serial Electrocardiograms for Acute Coronary Syndrome and Chest Pain. Completed, enrolled 382 participants across 1 site.

Detailed Summary

Our research will examine whether the presence or absence of serial electrocardiogram (ECG) changes aids in reclassifying participants' risk for major adverse cardiac events (MACE) over and above serial blood testing.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 30, 2013
Enrollment StartJan 1, 2013
Primary CompletionMay 1, 2015
Study CompletionJan 15, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.8 years ago

Interventions

Serial Electrocardiogramsdevice

All participants will have serial electrocardiograms performed.